Liquin, Arlyn .
HRN: 04-88-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2023
CEFUROXIME 500MG (TAB)
06/24/2023
06/29/2023
PO
500mg
BID X 5 More Days
S/P CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes